The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Endonasal Dacryocystorhinostomy (Endo-DCR)

Minimally invasive endoscopic procedure for nasolacrimal duct obstruction, creating a direct opening from the lacrimal sac into the nose to relieve epiphora and recurrent dacryocystitis.

Written by: Saygı Hospital Health Guide Editorial Board
Published:

This content is for general information; please consult your physician for diagnosis and treatment.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our KBB (Kulak Burun Boğaz) department. Book Appointment →

What is Endonasal Dacryocystorhinostomy (Endo-DCR)?

Nasolacrimal duct obstruction (NLDO) blocks tear flow from the puncta to the nasal cavity, causing epiphora (tearing), mucopurulent discharge, and recurrent dacryocystitis. Acquired primary NLDO is most common in middle-aged women; secondary causes include chronic dacryocystitis, trauma, sarcoidosis, granulomatosis with polyangiitis, sinus surgery, and post-radiotherapy fibrosis.

Endo-DCR uses rigid endoscopy with 0° and 30° telescopes to identify the lacrimal sac fossa, remove frontal process of the maxilla and lacrimal bone (with powered instruments or drill), incise the sac mucosa, and form a stable mucosa-to-mucosa anastomosis with the nasal lining. Silicone bicanalicular intubation may be used for 3–6 months.

Indications: chronic NLDO with epiphora, recurrent dacryocystitis, dacryocyst mucocele, failed external DCR. Contraindications: active acute dacryocystitis (treat infection first), nasal cavity tumor, severe nasal stenosis. Preoperative evaluation includes lacrimal probing/irrigation, nasal endoscopy, CT-DCG when anatomy is unclear, and culture if active infection.

Symptoms

Chronic epiphora (constant tearing), worse outdoors or with wind
Mucopurulent discharge from puncta on sac compression
Recurrent dacryocystitis (medial canthal swelling, redness, pain)
Dacryocystocele in infants and adults
Crusting at lid margin, conjunctival irritation
Failed previous balloon dacryoplasty or external DCR
Cosmetic concerns from chronic medial canthal mass

Risk Factors

Female gender, age 40–70 years
Chronic sinonasal inflammation
History of facial trauma or sinus surgery
Granulomatous diseases (sarcoidosis, GPA)
Radiotherapy to head and neck
Anatomical narrow nasolacrimal canal
Chronic punctal/canalicular stenosis

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Persistent epiphora despite probing/irrigation — oculoplastics or rhinology referral
  • Recurrent dacryocystitis episodes — definitive surgical drainage planning
  • Dacryocystocele in newborn — prompt referral
  • Acute dacryocystitis with cellulitis or abscess — emergency drainage and antibiotics
  • Persistent symptoms after Endo-DCR — re-evaluation for revision surgery

Treatment Methods

01
Preoperative: control of acute infection with oral antibiotics (amoxicillin-clavulanate), warm compresses, lacrimal irrigation
02
Endo-DCR technique: rigid 0°/30° endoscopy, identification of axilla of middle turbinate as landmark, mucosal flap, removal of bone with Kerrison rongeur or powered drill (~10–12 mm ostium), opening of sac with sickle knife, mucosa-to-mucosa anastomosis
03
Adjuncts: silicone bicanalicular stent for 3–6 months, mitomycin-C application in revision cases or scarring tendencies
04
Postoperative care: nasal saline irrigation, topical decongestant, antibiotic-steroid ointment to canthus, oral antibiotics 5–7 days
05
Outpatient follow-up at 1, 4, 12 weeks: endoscopic ostium check, lacrimal irrigation patency, stent removal at 3–6 months
06
Success rates: 85–95% primary, 70–85% revision; complications include bleeding, ostium closure, canalicular trauma, orbital injury (rare)
07
Combined endoscopic sinus surgery if concurrent chronic rhinosinusitis or septal deviation
08
Treatment of underlying systemic disease (sarcoidosis, GPA) crucial for long-term patency

Which Department to Visit?

You can visit our KBB (Kulak Burun Boğaz) department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About KBB (Kulak Burun Boğaz) Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.